Lithium Plus Minerals sruck a vein that is even 11 meters thicker (so far) than Core's BP33 find, which is one of the thickest hard rock spud sources identified. The properties are adjacent to each other (they're only two km apart).
In all likelihood, from what I've read so far, they're either two parts of the same massive deposit or they are cousins in a series of adjacent deposits. Both firms have plans to drill towards each other's massive finds, to determine that, AND both deposits are still deemed open at the bottom, and could run deeper than already determined.
In my opinion, Lithium Plus Minerals (LPM) has a market cap of less than $40M (USD), or just over $61M (AUD). CXO has roughly $250M (AUD) in the bank, with the recent CR. We still have to wait for official numbers, but it sounds like if CXO would purchase LPM, we could probably double our resource, for a pittance.
Given where we are, right now, I understand that BP33 development and plant optimization are our two biggest CAPEX issues, and there's the possibility of a midstream plant in the future, but acquiring LPM and doubling our resource (maybe even more), for this low of a price, would justify the CR, even at the ridiculous valuation. There is also the possibility of doing a share swap, but I would, personally, prefer not to be diluted anymore, and the money IS there.
I appreciate that there's Carlton, other nearby pegmatites and the Finnis Gold projects that also require some CAPEX, soon, but this is too good an opportunity to pass by. It's even better than all that, because since it is literally next door to our current facility, we would not need to build another plant, but expand and improve existing equipment.
- Forums
- ASX - By Stock
- Retail Needs to Band Together
CXO
core lithium ltd
Add to My Watchlist
0.00%
!
11.0¢

Lithium Plus Minerals sruck a vein that is even 11 meters...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $235.7M |
Open | High | Low | Value | Volume |
11.0¢ | 11.5¢ | 10.8¢ | $952.5K | 8.483M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 788130 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 3839464 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 458130 | 0.110 |
28 | 1585124 | 0.105 |
44 | 3313434 | 0.100 |
5 | 551881 | 0.099 |
6 | 254168 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 1915349 | 18 |
0.120 | 2659708 | 48 |
0.125 | 2147821 | 24 |
0.130 | 1173446 | 27 |
0.135 | 973962 | 16 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online